Nova Leap Health Corp (V:NLH) — Market Cap & Net Worth
Market Cap & Net Worth: Nova Leap Health Corp (NLH)
Nova Leap Health Corp (V:NLH) has a market capitalization of $22.74 Million (CA$31.43 Million) as of July 22, 2026. Listed on the V stock exchange, this Canada-based company holds position #24669 globally and #951 in its home market, demonstrating a -16.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nova Leap Health Corp's stock price CA$0.36 by its total outstanding shares 87314252 (87.31 Million). See capital reinvestment ratio of Nova Leap Health Corp to understand how much of operating cash flow is reinvested back into capital assets.
Nova Leap Health Corp Market Cap History: 2016 to 2026
Nova Leap Health Corp's market capitalization history from 2016 to 2026. Data shows growth from $13.26 Million to $22.74 Million (11.07% CAGR).
Nova Leap Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nova Leap Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
Nova Leap Health Corp's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.26 Million | $39.99K | -$489.52K | 331.67x | N/A |
| 2017 | $12.95 Million | $1.06 Million | -$851.61K | 12.22x | N/A |
| 2018 | $20.21 Million | $10.36 Million | -$961.27K | 1.95x | N/A |
| 2019 | $26.84 Million | $17.40 Million | -$1.06 Million | 1.54x | N/A |
| 2020 | $47.37 Million | $17.31 Million | $1.26 Million | 2.74x | 37.71x |
| 2021 | $38.53 Million | $21.28 Million | $1.76 Million | 1.81x | 21.88x |
| 2022 | $15.79 Million | $28.21 Million | -$835.75K | 0.56x | N/A |
| 2023 | $18.95 Million | $26.18 Million | -$1.05 Million | 0.72x | N/A |
| 2024 | $17.05 Million | $25.76 Million | $1.38 Million | 0.66x | 12.37x |
| 2025 | $17.69 Million | $31.47 Million | -$189.86K | 0.56x | N/A |
Competitor Companies of NLH by Market Capitalization
Companies near Nova Leap Health Corp in the global market cap rankings as of July 22, 2026.
Key companies related to Nova Leap Health Corp by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #328 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #930 globally with a market cap of $28.31 Billion USD ( €24.22 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #990 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1336 globally with a market cap of $18.86 Billion USD ( RM75.11 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $370.42 |
| #930 | Fresenius SE & Co. KGaA | XETRA:FRE | $28.31 Billion | €43.00 |
| #990 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1336 | IHH Healthcare Bhd | KLSE:5225 | $18.86 Billion | RM8.50 |
Nova Leap Health Corp Historical Marketcap From 2016 to 2026
Between 2016 and today, Nova Leap Health Corp's market cap moved from $13.26 Million to $ 22.74 Million, with a yearly change of 11.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$22.74 Million | +28.57% |
| 2025 | CA$17.69 Million | +3.70% |
| 2024 | CA$17.05 Million | -10.00% |
| 2023 | CA$18.95 Million | +20.00% |
| 2022 | CA$15.79 Million | -59.02% |
| 2021 | CA$38.53 Million | -18.67% |
| 2020 | CA$47.37 Million | +76.47% |
| 2019 | CA$26.84 Million | +32.81% |
| 2018 | CA$20.21 Million | +56.10% |
| 2017 | CA$12.95 Million | -2.38% |
| 2016 | CA$13.26 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of Nova Leap Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.74 Million USD |
| MoneyControl | $22.74 Million USD |
| MarketWatch | $22.74 Million USD |
| marketcap.company | $22.74 Million USD |
| Reuters | $22.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nova Leap Health Corp
Nova Leap Health Corp., together with its subsidiaries, provides home-based and community-based healthcare services in the United States and Canada. It offers home and home health care services, including dementia care, companionship, personal and skilled nursing care, respite care, palliative care, care management, cooking and meal preparation, light housekeeping, daily living activities, transp… Read more